๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carboplatin, 5-fluorouracil and folinic acid in advanced and recurrent squamous carcinoma of the head and neck

โœ Scribed by Junor, EJ; Canney, PA; Symonds, RP


Book ID
123476041
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
171 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cisplatin-5-fluorouracil chemotherapy fo
โœ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Wiley (John Wiley & Sons) โš– 368 KB ๐Ÿ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

Paclitaxel, cisplatin, and 5-fluorouraci
โœ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi